Scientists believe that because thymosin alpha-1 reduces the activity of these key cytokines, it might improve inflammation in PsA
Product innovation is focused on enhancing oral bioavailability, optimizing pharmacokinetic performance, enabling convenient once-daily dosing, and improving safety and tolerability profiles to maximize clinical outcomes
Ansari RA, Husain K, Rizvi SA
Exp Opinion Drug Metabol Toxicol 14(9):93750 Haghi-Aminjan H, Asghari MH, Farhood B, Rahimifard M, Hashemi Goradel N, Abdollahi M (2018) The role of melatonin on chemotherapy-induced reproductive toxicity
Based on the available preclinical research and practitioner experience, patients typically explore BPC-157 for the following concerns: BPC-157 is not a replacement for medical treatment